Janus Henderson Group’s Ortho Clinical Diagnostics Holdings OCDX Stock Holding History
Bought
Maintained
Sold
Other funds holding OCDX
Janus Henderson Group's OCDX Position: Q2 2022 in Review
Janus Henderson Group sold out of Ortho Clinical Diagnostics Holdings (OCDX) in Q2 2022, closing a stake of 4,476,193 shares — an estimated $83.5M sold.
Janus Henderson Group first reported a position in OCDX in Q1 2021 and held it in 5 quarters. The position peaked at $173M in Q4 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.
- Janus Henderson Group reported no remaining Ortho Clinical Diagnostics Holdings position as of Q2 2022 after selling out during the quarter.
- Janus Henderson Group sold 4,476,193 Ortho Clinical Diagnostics Holdings shares in Q2 2022, an estimated $83.5M.
- Janus Henderson Group first reported a position in Ortho Clinical Diagnostics Holdings in Q1 2021 and held it in 5 quarters.
- Janus Henderson Group's Ortho Clinical Diagnostics Holdings position peaked at $173M in Q4 2021.
- 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings as of Q2 2022.
Based on Janus Henderson Group's 13F filing for Q2 2022, filed 15 Aug 2022.